[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global HMO Infant Formula Market Growth 2023-2029

December 2023 | 106 pages | ID: G57E94135FB0EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global HMO Infant Formula market size was valued at US$ million in 2022. With growing demand in downstream market, the HMO Infant Formula is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.

The research report highlights the growth potential of the global HMO Infant Formula market. HMO Infant Formula are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of HMO Infant Formula. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the HMO Infant Formula market.

Key Features:

The report on HMO Infant Formula market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the HMO Infant Formula market. It may include historical data, market segmentation by Type (e.g., 2'-Fucosyllactose (2'-FL), 3-Fucosyllactose (3-FL)), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the HMO Infant Formula market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the HMO Infant Formula market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the HMO Infant Formula industry. This include advancements in HMO Infant Formula technology, HMO Infant Formula new entrants, HMO Infant Formula new investment, and other innovations that are shaping the future of HMO Infant Formula.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the HMO Infant Formula market. It includes factors influencing customer ' purchasing decisions, preferences for HMO Infant Formula product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the HMO Infant Formula market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting HMO Infant Formula market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the HMO Infant Formula market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the HMO Infant Formula industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the HMO Infant Formula market.

Market Segmentation:

HMO Infant Formula market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • 2'-Fucosyllactose (2'-FL)
  • 3-Fucosyllactose (3-FL)
  • Lactose-N-neotetraose (LNnT)
  • 3'-Sialyllactose (3'-SL)
  • 6'-Sialyllactose (6'-SL)
Segmentation by application
  • Online Channel
  • Specialty Store
  • Supermarket
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Abbott
  • Nestlй
  • Wyeth Nutrition
  • Hoeslandt
  • Friesland Foods
  • Hyproca
  • Aptamil
  • Biostime
  • Mengniu Dairy
  • Yili Group
  • Feihe
  • Junlebao Dairy Group
Key Questions Addressed in this Report

What is the 10-year outlook for the global HMO Infant Formula market?

What factors are driving HMO Infant Formula market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do HMO Infant Formula market opportunities vary by end market size?

How does HMO Infant Formula break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HMO Infant Formula Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for HMO Infant Formula by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for HMO Infant Formula by Country/Region, 2018, 2022 & 2029
2.2 HMO Infant Formula Segment by Type
  2.2.1 2'-Fucosyllactose (2'-FL)
  2.2.2 3-Fucosyllactose (3-FL)
  2.2.3 Lactose-N-neotetraose (LNnT)
  2.2.4 3'-Sialyllactose (3'-SL)
  2.2.5 6'-Sialyllactose (6'-SL)
2.3 HMO Infant Formula Sales by Type
  2.3.1 Global HMO Infant Formula Sales Market Share by Type (2018-2023)
  2.3.2 Global HMO Infant Formula Revenue and Market Share by Type (2018-2023)
  2.3.3 Global HMO Infant Formula Sale Price by Type (2018-2023)
2.4 HMO Infant Formula Segment by Application
  2.4.1 Online Channel
  2.4.2 Specialty Store
  2.4.3 Supermarket
  2.4.4 Other
2.5 HMO Infant Formula Sales by Application
  2.5.1 Global HMO Infant Formula Sale Market Share by Application (2018-2023)
  2.5.2 Global HMO Infant Formula Revenue and Market Share by Application (2018-2023)
  2.5.3 Global HMO Infant Formula Sale Price by Application (2018-2023)

3 GLOBAL HMO INFANT FORMULA BY COMPANY

3.1 Global HMO Infant Formula Breakdown Data by Company
  3.1.1 Global HMO Infant Formula Annual Sales by Company (2018-2023)
  3.1.2 Global HMO Infant Formula Sales Market Share by Company (2018-2023)
3.2 Global HMO Infant Formula Annual Revenue by Company (2018-2023)
  3.2.1 Global HMO Infant Formula Revenue by Company (2018-2023)
  3.2.2 Global HMO Infant Formula Revenue Market Share by Company (2018-2023)
3.3 Global HMO Infant Formula Sale Price by Company
3.4 Key Manufacturers HMO Infant Formula Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers HMO Infant Formula Product Location Distribution
  3.4.2 Players HMO Infant Formula Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR HMO INFANT FORMULA BY GEOGRAPHIC REGION

4.1 World Historic HMO Infant Formula Market Size by Geographic Region (2018-2023)
  4.1.1 Global HMO Infant Formula Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global HMO Infant Formula Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic HMO Infant Formula Market Size by Country/Region (2018-2023)
  4.2.1 Global HMO Infant Formula Annual Sales by Country/Region (2018-2023)
  4.2.2 Global HMO Infant Formula Annual Revenue by Country/Region (2018-2023)
4.3 Americas HMO Infant Formula Sales Growth
4.4 APAC HMO Infant Formula Sales Growth
4.5 Europe HMO Infant Formula Sales Growth
4.6 Middle East & Africa HMO Infant Formula Sales Growth

5 AMERICAS

5.1 Americas HMO Infant Formula Sales by Country
  5.1.1 Americas HMO Infant Formula Sales by Country (2018-2023)
  5.1.2 Americas HMO Infant Formula Revenue by Country (2018-2023)
5.2 Americas HMO Infant Formula Sales by Type
5.3 Americas HMO Infant Formula Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC HMO Infant Formula Sales by Region
  6.1.1 APAC HMO Infant Formula Sales by Region (2018-2023)
  6.1.2 APAC HMO Infant Formula Revenue by Region (2018-2023)
6.2 APAC HMO Infant Formula Sales by Type
6.3 APAC HMO Infant Formula Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe HMO Infant Formula by Country
  7.1.1 Europe HMO Infant Formula Sales by Country (2018-2023)
  7.1.2 Europe HMO Infant Formula Revenue by Country (2018-2023)
7.2 Europe HMO Infant Formula Sales by Type
7.3 Europe HMO Infant Formula Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HMO Infant Formula by Country
  8.1.1 Middle East & Africa HMO Infant Formula Sales by Country (2018-2023)
  8.1.2 Middle East & Africa HMO Infant Formula Revenue by Country (2018-2023)
8.2 Middle East & Africa HMO Infant Formula Sales by Type
8.3 Middle East & Africa HMO Infant Formula Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HMO Infant Formula
10.3 Manufacturing Process Analysis of HMO Infant Formula
10.4 Industry Chain Structure of HMO Infant Formula

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 HMO Infant Formula Distributors
11.3 HMO Infant Formula Customer

12 WORLD FORECAST REVIEW FOR HMO INFANT FORMULA BY GEOGRAPHIC REGION

12.1 Global HMO Infant Formula Market Size Forecast by Region
  12.1.1 Global HMO Infant Formula Forecast by Region (2024-2029)
  12.1.2 Global HMO Infant Formula Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global HMO Infant Formula Forecast by Type
12.7 Global HMO Infant Formula Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Abbott
  13.1.1 Abbott Company Information
  13.1.2 Abbott HMO Infant Formula Product Portfolios and Specifications
  13.1.3 Abbott HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Abbott Main Business Overview
  13.1.5 Abbott Latest Developments
13.2 Nestlй
  13.2.1 Nestlй Company Information
  13.2.2 Nestlй HMO Infant Formula Product Portfolios and Specifications
  13.2.3 Nestlй HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Nestlй Main Business Overview
  13.2.5 Nestlй Latest Developments
13.3 Wyeth Nutrition
  13.3.1 Wyeth Nutrition Company Information
  13.3.2 Wyeth Nutrition HMO Infant Formula Product Portfolios and Specifications
  13.3.3 Wyeth Nutrition HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Wyeth Nutrition Main Business Overview
  13.3.5 Wyeth Nutrition Latest Developments
13.4 Hoeslandt
  13.4.1 Hoeslandt Company Information
  13.4.2 Hoeslandt HMO Infant Formula Product Portfolios and Specifications
  13.4.3 Hoeslandt HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Hoeslandt Main Business Overview
  13.4.5 Hoeslandt Latest Developments
13.5 Friesland Foods
  13.5.1 Friesland Foods Company Information
  13.5.2 Friesland Foods HMO Infant Formula Product Portfolios and Specifications
  13.5.3 Friesland Foods HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Friesland Foods Main Business Overview
  13.5.5 Friesland Foods Latest Developments
13.6 Hyproca
  13.6.1 Hyproca Company Information
  13.6.2 Hyproca HMO Infant Formula Product Portfolios and Specifications
  13.6.3 Hyproca HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Hyproca Main Business Overview
  13.6.5 Hyproca Latest Developments
13.7 Aptamil
  13.7.1 Aptamil Company Information
  13.7.2 Aptamil HMO Infant Formula Product Portfolios and Specifications
  13.7.3 Aptamil HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Aptamil Main Business Overview
  13.7.5 Aptamil Latest Developments
13.8 Biostime
  13.8.1 Biostime Company Information
  13.8.2 Biostime HMO Infant Formula Product Portfolios and Specifications
  13.8.3 Biostime HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Biostime Main Business Overview
  13.8.5 Biostime Latest Developments
13.9 Mengniu Dairy
  13.9.1 Mengniu Dairy Company Information
  13.9.2 Mengniu Dairy HMO Infant Formula Product Portfolios and Specifications
  13.9.3 Mengniu Dairy HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Mengniu Dairy Main Business Overview
  13.9.5 Mengniu Dairy Latest Developments
13.10 Yili Group
  13.10.1 Yili Group Company Information
  13.10.2 Yili Group HMO Infant Formula Product Portfolios and Specifications
  13.10.3 Yili Group HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Yili Group Main Business Overview
  13.10.5 Yili Group Latest Developments
13.11 Feihe
  13.11.1 Feihe Company Information
  13.11.2 Feihe HMO Infant Formula Product Portfolios and Specifications
  13.11.3 Feihe HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Feihe Main Business Overview
  13.11.5 Feihe Latest Developments
13.12 Junlebao Dairy Group
  13.12.1 Junlebao Dairy Group Company Information
  13.12.2 Junlebao Dairy Group HMO Infant Formula Product Portfolios and Specifications
  13.12.3 Junlebao Dairy Group HMO Infant Formula Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Junlebao Dairy Group Main Business Overview
  13.12.5 Junlebao Dairy Group Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. HMO Infant Formula Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. HMO Infant Formula Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 2'-Fucosyllactose (2'-FL)
Table 4. Major Players of 3-Fucosyllactose (3-FL)
Table 5. Major Players of Lactose-N-neotetraose (LNnT)
Table 6. Major Players of 3'-Sialyllactose (3'-SL)
Table 7. Major Players of 6'-Sialyllactose (6'-SL)
Table 8. Global HMO Infant Formula Sales by Type (2018-2023) & (Tons)
Table 9. Global HMO Infant Formula Sales Market Share by Type (2018-2023)
Table 10. Global HMO Infant Formula Revenue by Type (2018-2023) & ($ million)
Table 11. Global HMO Infant Formula Revenue Market Share by Type (2018-2023)
Table 12. Global HMO Infant Formula Sale Price by Type (2018-2023) & (US$/Ton)
Table 13. Global HMO Infant Formula Sales by Application (2018-2023) & (Tons)
Table 14. Global HMO Infant Formula Sales Market Share by Application (2018-2023)
Table 15. Global HMO Infant Formula Revenue by Application (2018-2023)
Table 16. Global HMO Infant Formula Revenue Market Share by Application (2018-2023)
Table 17. Global HMO Infant Formula Sale Price by Application (2018-2023) & (US$/Ton)
Table 18. Global HMO Infant Formula Sales by Company (2018-2023) & (Tons)
Table 19. Global HMO Infant Formula Sales Market Share by Company (2018-2023)
Table 20. Global HMO Infant Formula Revenue by Company (2018-2023) ($ Millions)
Table 21. Global HMO Infant Formula Revenue Market Share by Company (2018-2023)
Table 22. Global HMO Infant Formula Sale Price by Company (2018-2023) & (US$/Ton)
Table 23. Key Manufacturers HMO Infant Formula Producing Area Distribution and Sales Area
Table 24. Players HMO Infant Formula Products Offered
Table 25. HMO Infant Formula Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global HMO Infant Formula Sales by Geographic Region (2018-2023) & (Tons)
Table 29. Global HMO Infant Formula Sales Market Share Geographic Region (2018-2023)
Table 30. Global HMO Infant Formula Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global HMO Infant Formula Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global HMO Infant Formula Sales by Country/Region (2018-2023) & (Tons)
Table 33. Global HMO Infant Formula Sales Market Share by Country/Region (2018-2023)
Table 34. Global HMO Infant Formula Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global HMO Infant Formula Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas HMO Infant Formula Sales by Country (2018-2023) & (Tons)
Table 37. Americas HMO Infant Formula Sales Market Share by Country (2018-2023)
Table 38. Americas HMO Infant Formula Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas HMO Infant Formula Revenue Market Share by Country (2018-2023)
Table 40. Americas HMO Infant Formula Sales by Type (2018-2023) & (Tons)
Table 41. Americas HMO Infant Formula Sales by Application (2018-2023) & (Tons)
Table 42. APAC HMO Infant Formula Sales by Region (2018-2023) & (Tons)
Table 43. APAC HMO Infant Formula Sales Market Share by Region (2018-2023)
Table 44. APAC HMO Infant Formula Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC HMO Infant Formula Revenue Market Share by Region (2018-2023)
Table 46. APAC HMO Infant Formula Sales by Type (2018-2023) & (Tons)
Table 47. APAC HMO Infant Formula Sales by Application (2018-2023) & (Tons)
Table 48. Europe HMO Infant Formula Sales by Country (2018-2023) & (Tons)
Table 49. Europe HMO Infant Formula Sales Market Share by Country (2018-2023)
Table 50. Europe HMO Infant Formula Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe HMO Infant Formula Revenue Market Share by Country (2018-2023)
Table 52. Europe HMO Infant Formula Sales by Type (2018-2023) & (Tons)
Table 53. Europe HMO Infant Formula Sales by Application (2018-2023) & (Tons)
Table 54. Middle East & Africa HMO Infant Formula Sales by Country (2018-2023) & (Tons)
Table 55. Middle East & Africa HMO Infant Formula Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa HMO Infant Formula Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa HMO Infant Formula Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa HMO Infant Formula Sales by Type (2018-2023) & (Tons)
Table 59. Middle East & Africa HMO Infant Formula Sales by Application (2018-2023) & (Tons)
Table 60. Key Market Drivers & Growth Opportunities of HMO Infant Formula
Table 61. Key Market Challenges & Risks of HMO Infant Formula
Table 62. Key Industry Trends of HMO Infant Formula
Table 63. HMO Infant Formula Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. HMO Infant Formula Distributors List
Table 66. HMO Infant Formula Customer List
Table 67. Global HMO Infant Formula Sales Forecast by Region (2024-2029) & (Tons)
Table 68. Global HMO Infant Formula Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas HMO Infant Formula Sales Forecast by Country (2024-2029) & (Tons)
Table 70. Americas HMO Infant Formula Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC HMO Infant Formula Sales Forecast by Region (2024-2029) & (Tons)
Table 72. APAC HMO Infant Formula Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe HMO Infant Formula Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Europe HMO Infant Formula Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa HMO Infant Formula Sales Forecast by Country (2024-2029) & (Tons)
Table 76. Middle East & Africa HMO Infant Formula Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global HMO Infant Formula Sales Forecast by Type (2024-2029) & (Tons)
Table 78. Global HMO Infant Formula Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global HMO Infant Formula Sales Forecast by Application (2024-2029) & (Tons)
Table 80. Global HMO Infant Formula Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Abbott Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 82. Abbott HMO Infant Formula Product Portfolios and Specifications
Table 83. Abbott HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 84. Abbott Main Business
Table 85. Abbott Latest Developments
Table 86. Nestlй Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 87. Nestlй HMO Infant Formula Product Portfolios and Specifications
Table 88. Nestlй HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 89. Nestlй Main Business
Table 90. Nestlй Latest Developments
Table 91. Wyeth Nutrition Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 92. Wyeth Nutrition HMO Infant Formula Product Portfolios and Specifications
Table 93. Wyeth Nutrition HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 94. Wyeth Nutrition Main Business
Table 95. Wyeth Nutrition Latest Developments
Table 96. Hoeslandt Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 97. Hoeslandt HMO Infant Formula Product Portfolios and Specifications
Table 98. Hoeslandt HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 99. Hoeslandt Main Business
Table 100. Hoeslandt Latest Developments
Table 101. Friesland Foods Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 102. Friesland Foods HMO Infant Formula Product Portfolios and Specifications
Table 103. Friesland Foods HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 104. Friesland Foods Main Business
Table 105. Friesland Foods Latest Developments
Table 106. Hyproca Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 107. Hyproca HMO Infant Formula Product Portfolios and Specifications
Table 108. Hyproca HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 109. Hyproca Main Business
Table 110. Hyproca Latest Developments
Table 111. Aptamil Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 112. Aptamil HMO Infant Formula Product Portfolios and Specifications
Table 113. Aptamil HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 114. Aptamil Main Business
Table 115. Aptamil Latest Developments
Table 116. Biostime Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 117. Biostime HMO Infant Formula Product Portfolios and Specifications
Table 118. Biostime HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 119. Biostime Main Business
Table 120. Biostime Latest Developments
Table 121. Mengniu Dairy Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 122. Mengniu Dairy HMO Infant Formula Product Portfolios and Specifications
Table 123. Mengniu Dairy HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 124. Mengniu Dairy Main Business
Table 125. Mengniu Dairy Latest Developments
Table 126. Yili Group Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 127. Yili Group HMO Infant Formula Product Portfolios and Specifications
Table 128. Yili Group HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 129. Yili Group Main Business
Table 130. Yili Group Latest Developments
Table 131. Feihe Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 132. Feihe HMO Infant Formula Product Portfolios and Specifications
Table 133. Feihe HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 134. Feihe Main Business
Table 135. Feihe Latest Developments
Table 136. Junlebao Dairy Group Basic Information, HMO Infant Formula Manufacturing Base, Sales Area and Its Competitors
Table 137. Junlebao Dairy Group HMO Infant Formula Product Portfolios and Specifications
Table 138. Junlebao Dairy Group HMO Infant Formula Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 139. Junlebao Dairy Group Main Business
Table 140. Junlebao Dairy Group Latest Developments

LIST OF FIGURES

Figure 1. Picture of HMO Infant Formula
Figure 2. HMO Infant Formula Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HMO Infant Formula Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global HMO Infant Formula Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. HMO Infant Formula Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 2'-Fucosyllactose (2'-FL)
Figure 10. Product Picture of 3-Fucosyllactose (3-FL)
Figure 11. Product Picture of Lactose-N-neotetraose (LNnT)
Figure 12. Product Picture of 3'-Sialyllactose (3'-SL)
Figure 13. Product Picture of 6'-Sialyllactose (6'-SL)
Figure 14. Global HMO Infant Formula Sales Market Share by Type in 2022
Figure 15. Global HMO Infant Formula Revenue Market Share by Type (2018-2023)
Figure 16. HMO Infant Formula Consumed in Online Channel
Figure 17. Global HMO Infant Formula Market: Online Channel (2018-2023) & (Tons)
Figure 18. HMO Infant Formula Consumed in Specialty Store
Figure 19. Global HMO Infant Formula Market: Specialty Store (2018-2023) & (Tons)
Figure 20. HMO Infant Formula Consumed in Supermarket
Figure 21. Global HMO Infant Formula Market: Supermarket (2018-2023) & (Tons)
Figure 22. HMO Infant Formula Consumed in Other
Figure 23. Global HMO Infant Formula Market: Other (2018-2023) & (Tons)
Figure 24. Global HMO Infant Formula Sales Market Share by Application (2022)
Figure 25. Global HMO Infant Formula Revenue Market Share by Application in 2022
Figure 26. HMO Infant Formula Sales Market by Company in 2022 (Tons)
Figure 27. Global HMO Infant Formula Sales Market Share by Company in 2022
Figure 28. HMO Infant Formula Revenue Market by Company in 2022 ($ Million)
Figure 29. Global HMO Infant Formula Revenue Market Share by Company in 2022
Figure 30. Global HMO Infant Formula Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global HMO Infant Formula Revenue Market Share by Geographic Region in 2022
Figure 32. Americas HMO Infant Formula Sales 2018-2023 (Tons)
Figure 33. Americas HMO Infant Formula Revenue 2018-2023 ($ Millions)
Figure 34. APAC HMO Infant Formula Sales 2018-2023 (Tons)
Figure 35. APAC HMO Infant Formula Revenue 2018-2023 ($ Millions)
Figure 36. Europe HMO Infant Formula Sales 2018-2023 (Tons)
Figure 37. Europe HMO Infant Formula Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa HMO Infant Formula Sales 2018-2023 (Tons)
Figure 39. Middle East & Africa HMO Infant Formula Revenue 2018-2023 ($ Millions)
Figure 40. Americas HMO Infant Formula Sales Market Share by Country in 2022
Figure 41. Americas HMO Infant Formula Revenue Market Share by Country in 2022
Figure 42. Americas HMO Infant Formula Sales Market Share by Type (2018-2023)
Figure 43. Americas HMO Infant Formula Sales Market Share by Application (2018-2023)
Figure 44. United States HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC HMO Infant Formula Sales Market Share by Region in 2022
Figure 49. APAC HMO Infant Formula Revenue Market Share by Regions in 2022
Figure 50. APAC HMO Infant Formula Sales Market Share by Type (2018-2023)
Figure 51. APAC HMO Infant Formula Sales Market Share by Application (2018-2023)
Figure 52. China HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 56. India HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe HMO Infant Formula Sales Market Share by Country in 2022
Figure 60. Europe HMO Infant Formula Revenue Market Share by Country in 2022
Figure 61. Europe HMO Infant Formula Sales Market Share by Type (2018-2023)
Figure 62. Europe HMO Infant Formula Sales Market Share by Application (2018-2023)
Figure 63. Germany HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 64. France HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa HMO Infant Formula Sales Market Share by Country in 2022
Figure 69. Middle East & Africa HMO Infant Formula Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa HMO Infant Formula Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa HMO Infant Formula Sales Market Share by Application (2018-2023)
Figure 72. Egypt HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country HMO Infant Formula Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of HMO Infant Formula in 2022
Figure 78. Manufacturing Process Analysis of HMO Infant Formula
Figure 79. Industry Chain Structure of HMO Infant Formula
Figure 80. Channels of Distribution
Figure 81. Global HMO Infant Formula Sales Market Forecast by Region (2024-2029)
Figure 82. Global HMO Infant Formula Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global HMO Infant Formula Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global HMO Infant Formula Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global HMO Infant Formula Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global HMO Infant Formula Revenue Market Share Forecast by Application (2024-2029)


More Publications